Centre d'Investigation Clinique - INSERM 1406
Grenoble, Isere, 38043, France
NCT Number: NCT02682290
This is a proof of concept study. The aim of this study is to assess a device measuring rheological properties of human sputum of four populations :
* 10 patients with Broncho Chronic Obstructive Pulmonary Disease (COPD) * 10 patients with asthma * 10 patients with cystic fibrosis * 10 healthy volunteers.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Grenoble, Isere, 38043, France
This study includes two visits to 48 hours apart.
During the first visit :
During the second visit :
A control spirometry will be perform before each expectoration and during induced expectoration if necessary.
All sputum sample collected will be homogenized and then divided into two equal volumes in order to perform two separate rheological measurements of 15 minutes.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
of healthy volunteers:
Exclusion criteria
of healthy volunteers:
Inclusion criteria
of patients with cystic fibrosis:
Exclusion criteria
of patients with cystic fibrosis:
Inclusion criteria
of patients with COPD:
Exclusion criteria
of patients with COPD:
Inclusion criteria
of patients with asthma:
Exclusion criteria
of patients with COPD:
Time frame: Day1 (at the first visit)
The reproducibility will be assessed during the first visit (Day1). The two rheological measurements performed 15 minutes apart will be compared.
Rheological measurements : elastic modulus G' at 0.7Hz, elastic modulus G' at 3Hz, viscous modulus G'' at 0.7Hz, viscous modulus G'' at 3Hz)
Time frame: Day3 (48h00 after day1)
Comparison between the average of the two rheological measurements preformed at the first visit (Day1) and the average of the two rheological measurements preformed at the second visit (day3) 48 hours later.
Time frame: Day1 (at the first visit) and day3 (48h00 after day1)
frequency of measurements failure
Time frame: Day1 (at the first visit) and day3 (48h00 after day1)
Time frame: Day1 (at the first visit) and day3 (48h00 after day1)
During the first visit (day1), for patients with cystic fibrosis: Comparison of rheological parameters before and after nebulization of saline solution.
During second visit (day 3) for patients with cystic fibrosis: Comparison of rheological parameters before and after nebulization of 2.5 ml of RhDNAse.
University Hospital, Grenoble
Other
Assessment of a Device Used for Measuring the Rheological Parameters of Human Sputum.
Acronym: RHEOMUCO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04574050
Anemia, Anemia, Hemolytic
London, United Kingdom
View Trial DetailsNCT00677560
Asthma, Bronchial Diseases
London, United Kingdom
View Trial DetailsNCT00504361
Asthma, Bronchial Diseases
Doha, Qatar
View Trial DetailsNCT00362739
Asthma, Bronchial Diseases
New York, United States
View Trial Details